SCHEMBL9529942

SCHEMBL9529942

O=C(O)CSc1sccc1C1OCCO1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ALDH1A1 P00352 3/20 0.35
POLB P06746 1/20 0.35
FFAR1 O14842 1/20 0.35
KDM4E B2RXH2 2/20 0.34
APEX1 P27695 1/20 0.33
KEAP1 Q14145 1/20 0.32
SLC22A12 Q96S37 1/20 0.32
GRK6 P43250 1/20 0.32
CDC25B P30305 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
PHGDH O43175 1/20 0.30
MAPT P10636 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2277778 0.81 ALDH1A1 (0.41) CYP1A2CYP3A4CYP2C19HSD17B10ALDH1A1
SCHEMBL5632525 0.71 CYP1A2 (0.46) CYP1A2CYP3A4CYP2C19HSD17B10ALDH1A1
SCHEMBL9350805 0.69 CYP1A2 (0.44) CYP1A2CYP3A4CYP2C19HSD17B10ALDH1A1
SCHEMBL9353590 0.69 CYP1A2 (0.44) CYP1A2CYP3A4CYP2C19HSD17B10ALDH1A1
SCHEMBL9528983 0.67 CYP1A2 (0.42) CYP1A2CYP3A4CYP2C19HSD17B10ALDH1A1
SCHEMBL11717863 0.66 KMT2A (0.41) CYP1A2CYP3A4CYP2C19HSD17B10ALDH1A1
SCHEMBL470176 0.64 KEAP1 (0.38) ALDH1A1POLBKEAP1
SCHEMBL3057133 0.64 ALDH1A1 (0.44) ALDH1A1POLBKEAP1
SCHEMBL3101559 0.63 ALDH1A1 (0.40) ALDH1A1POLBKEAP1MEN1KMT2A
SCHEMBL6420253 0.63 KEAP1 (0.37) ALDH1A1POLBKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0307084-B1 Substituted thieno(2,3-b)thiophene-2-sulfonamides as antiglaucoma agents MERCK & CO INC (US) 1993-12-15 EP disclosed
EP-0541705-A4 SUBSTITUTED 1H-IMIDAZOL-5-YL)ALKANOIC ACIDS 1993-11-10 EP disclosed
EP-0541705-A1 SUBSTITUTED 1H-IMIDAZOL-5-YL]ALKANOIC ACIDS SMITHKLINE BEECHAM CORPORATION (US) 1993-05-19 EP disclosed
EP-0366178-B1 5-[N-methoxyethyl-N-methoxyethoxyethyl)aminomethyl]thieno [2,3-b] thiophene-2-sulfonamide as antiglaucoma agents MERCK & CO. INC. (US) 1992-06-17 EP disclosed
EP-0366178-A1 5-[N-methoxyethyl-N-methoxyethoxyethyl)aminomethyl]thieno [2,3-b] thiophene-2-sulfonamide as antiglaucoma agents MERCK & CO. INC. (US) 1990-05-02 EP disclosed
US-4894390-A VISION DEFECTS MERCK & CO., INC. (US) 1990-01-16 US disclosed
EP-0307084-A1 Substituted thieno(2,3-b)thiophene-2-sulfonamides as antiglaucoma agents MERCK & CO. INC. (US) 1989-03-15 EP disclosed
US-4806562-A Substituted thieno[2,3-b]thiophene-2-sulfonamides as antiglaucoma agents MERCK & CO., INC. (US) 1989-02-21 US disclosed